Shamburg News · 8-K filed Nov 16, 2026, 10:17 AM EST

Rapid Micro Biosystems Reports Q3 2026 Results and Agreement to Be Acquired by Merck KGaA

RPID · RAPID MICRO BIOSYSTEMS, INC.

  • Earnings
  • Acquisition
  • Material agreement
  • Other event
  • Materiality: high

Rapid Micro Biosystems, Inc. reported third quarter 2026 total revenue of $9.5 million, up 21.6% from $7.8 million a year earlier, and a net loss of $11.3 million, or $0.23 per share, compared with a net loss of $11.5 million, or $0.26 per share, in the prior-year quarter. The company also announced a definitive agreement to be acquired by Merck KGaA, Darmstadt, Germany, will not host a conference call, is withdrawing its full year 2026 guidance, and will delay its Form 10-Q filing under Rule 12b-25. Non-GAAP adjusted EBITDA loss was $7.9 million for the quarter, and cash, cash equivalents and short-term investments were approximately $7 million as of September 30, 2026.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Items 2.02, 9.01, accession 0001380106-26-000110.

Written from the filing by Shamburg Markets. Figures are as reported by the company.